Singh PK, Jain A. Epidemiological perspective of drug resistant extrapulmonary tuberculosis. World J Clin Infect Dis 2015; 5(4): 77-85 [DOI: 10.5495/wjcid.v5.i4.77]
Corresponding Author of This Article
Amita Jain, Professor, Department of Microbiology, King George’s Medical University, Shah Mina Road, Chowk, Lucknow, Uttar Pradesh 226003, India. amita602002@yahoo.com
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Infect Dis. Nov 25, 2015; 5(4): 77-85 Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.77
Epidemiological perspective of drug resistant extrapulmonary tuberculosis
Pravin Kumar Singh, Amita Jain
Pravin Kumar Singh, Amita Jain, Department of Microbiology, King George’s Medical University, Lucknow, Uttar Pradesh 226003, India
Author contributions: Both the authors collected the relevant information and wrote the paper.
Conflict-of-interest statement: Pravin Kumar Singh is employed by Foundation for Innovative New Diagnostic, however author alone is responsible for the views expressed in this paper.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Amita Jain, Professor, Department of Microbiology, King George’s Medical University, Shah Mina Road, Chowk, Lucknow, Uttar Pradesh 226003, India. amita602002@yahoo.com
Telephone: +91-522-2258633 Fax: +91-522-2258633
Received: January 15, 2015 Peer-review started: January 16, 2015 First decision: March 20, 2015 Revised: August 11, 2015 Accepted: September 7, 2015 Article in press: September 8, 2015 Published online: November 25, 2015
Core Tip
Core tip: The emergence of highly drug resistant (DR) Mycobacterium tuberculosis and human immunodeficiency virus epidemic has paved the way for resurgence of tuberculosis (TB). Extrapulmonary tuberculosis (EPTB), accounts for a significant proportion of all notified TB cases, is a persistent global health issue. Although DR-EPTB is uncommon, but the increasing rate of DR-pulmonary TB around the world has heightened our concern for DR-EPTB too. Unfortunately, systematic surveillance data on DR-EPTB is lacking, however, sporadic information from different countries has begun to accumulate. Here, we aim to provide current understanding on epidemiological scenario of DR-EPTB and also to address some of the key challenges associated with diagnosis, control and management of DR-EPTB.
